02 Dec SAHPRA registers new long-acting HIV Pre-exposure prophylaxis
Pretoria, 2 December 2022 – The South African Health Products Regulatory Authority (SAHPRA) has registered Cabotegravir (Apretude 600 mg/3ml injection), a long-acting HIV pre-exposure prophylactic. Cabotegravir is an antiretroviral drug (ARV) that people living with HIV may use, together with other ARVs, to keep the virus...